721 results
Responsible body
CHMP Remove CHMP filter
-
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 June 2020 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 22/06/2020 to 25/06/2020, Last updated: 26/06/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2020
CHMP, Last updated: 26/06/2020 -
List item
Press release: New medicine for cystic fibrosis patients
CHMP, Last updated: 26/06/2020 -
List item
Press release: New treatment to enable kidney transplant in highly sensitised patients
CHMP, Last updated: 26/06/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 28-30 April 2020 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 28/04/2020 to 30/04/2020, Last updated: 24/06/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 March 2020 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 23/03/2020 to 26/03/2020, Last updated: 17/06/2020 -
List item
Press release: New vaccine for prevention of Ebola virus disease recommended for approval in the European Union
CHMP, Last updated: 29/05/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 May 2020
CHMP, Last updated: 29/05/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 February 2020
European Medicines Agency, Amsterdam, the Netherlands, from 24/02/2020 to 27/02/2020, Last updated: 28/05/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-28 May 2020
European Medicines Agency, Amsterdam, the Netherlands, from 25/05/2020 to 28/05/2020, Last updated: 27/05/2020 -
List item
News: Update of EU recommendations for 2020/2021 seasonal flu vaccine composition
CHMP, Last updated: 15/05/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020 -
List item
Press release: Risks of Picato for actinic keratosis outweigh benefits
CHMP, Last updated: 30/04/2020 -
List item
Press release: Suspension of ranitidine medicines in the EU
CHMP, Last updated: 30/04/2020 -
List item
Press release: First triple combination therapy for asthma with optional electronic sensor
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA provides recommendations on compassionate use of remdesivir for COVID-19
CHMP, Last updated: 03/04/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 27-30 January 2020
European Medicines Agency, Amsterdam, the Netherlands, from 27/01/2020 to 30/01/2020, Last updated: 02/04/2020 -
List item
News: EU recommendations for 2020/2021 seasonal flu vaccine composition
CHMP, Last updated: 01/04/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 09-12 December 2019
European Medicines Agency, Amsterdam, the Netherlands, from 09/12/2019 to 12/12/2019, Last updated: 30/03/2020 -
List item
Press release: No change to product information for breast cancer medicine Tyverb following re-assessment of data
CHMP, Last updated: 27/03/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 March 2020 (updated)
CHMP, Last updated: 27/03/2020 -
List item
Press release: New gene therapy to treat spinal muscular atrophy (corrected)
CHMP, Last updated: 27/03/2020 -
List item
Press release: No change is needed in use of direct oral anticoagulants following EMA-funded study
CHMP, Last updated: 27/03/2020 -
List item
Press release: Recommendations to restrict use of fosfomycin antibiotics
CHMP, Last updated: 27/03/2020